339 related articles for article (PubMed ID: 14754602)
1. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Carlo-Stella C; Cazzola M; Bernasconi P; Bergamaschi G; Dezza L; Pedrazzoli P; Rosti V; Tomaselli S; Zappone E
Haematologica; 1989; 74(2):181-6. PubMed ID: 2501171
[TBL] [Abstract][Full Text] [Related]
3. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
4. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.
Delforge M; Demuynck H; Verhoef G; Vandenberghe P; Zachée P; Maertens J; Van Duppen V; Boogaerts MA
Br J Haematol; 1998 Jul; 102(2):486-94. PubMed ID: 9695963
[TBL] [Abstract][Full Text] [Related]
5. [Cell clonality in myelodysplastic syndrome].
Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
[TBL] [Abstract][Full Text] [Related]
6. [Clonal study of hematopoietic cells].
Jinnai I
Rinsho Ketsueki; 1995 Apr; 36(4):273-8. PubMed ID: 7783329
[TBL] [Abstract][Full Text] [Related]
7. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
8. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
9. [Myelodysplastic syndromes in two young brothers].
Yabe H; Matsushita A; Ichiba S; Nagai K; Nakayama S
Rinsho Ketsueki; 1992 Feb; 33(2):184-8. PubMed ID: 1635166
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
12. Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.
Tiu R; Gondek L; O'Keefe C; Maciejewski JP
Leukemia; 2007 Aug; 21(8):1648-57. PubMed ID: 17554386
[TBL] [Abstract][Full Text] [Related]
13. Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cell.
Malcovati L; La Starza R; Merante S; Pietra D; Mecucci C; Cazzola M
Haematologica; 2004 Apr; 89(4):497-9. PubMed ID: 15075087
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
15. Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors.
Suzuki H; Asano H; Ohashi H; Kinoshita T; Murate T; Saito H; Hotta T
Leukemia; 1999 Jan; 13(1):130-4. PubMed ID: 10049048
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes.
Delforge M; Demuynck H; Vandenberghe P; Verhoef G; Zachée P; van Duppen V; Marijnen P; Van den Berghe H; Boogaerts MA
Blood; 1995 Nov; 86(10):3660-7. PubMed ID: 7579331
[TBL] [Abstract][Full Text] [Related]
17. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
[TBL] [Abstract][Full Text] [Related]
18. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
19. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.
Catalano L; Selleri C; Califano C; Luciano L; Volpicelli M; Rocco S; Varriale G; Ricci P; Rotoli B
Haematologica; 2000 Feb; 85(2):133-8. PubMed ID: 10681719
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
